melatonin and fluvoxamine

melatonin has been researched along with fluvoxamine in 22 studies

Research

Studies (22)

TimeframeStudies, this research(%)All Research%
pre-19903 (13.64)18.7374
1990's4 (18.18)18.2507
2000's9 (40.91)29.6817
2010's4 (18.18)24.3611
2020's2 (9.09)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Durlach-Misteli, C; Van Ree, JM1
Den Boer, JA; Westenberg, HG1
Althoff, PH; Bochnik, HJ; Demisch, K; Demisch, L; Nickelsen, T; Rieth, R; Schöffling, K1
Demisch, K; Demisch, L; Nickelsen, T; Rieth, R1
Demisch, K; Demisch, L; Gerbaldo, H1
Arendt, J; Bojkowski, CJ; Skene, DJ1
Barash, I; Jahjah, N; Mizruhin, A; Odnopozov, N; Silver, H1
Grözinger, M; Härtter, S; Hiemke, C; Röschke, J; Weigmann, H1
Bertilsson, L; Röjdmark, S; Tybring, G; Ursing, C; von Bahr, C; Yasui, N1
Grözinger, M; Härtter, S; Hiemke, C; Röschke, J; Rose, DM; Wang, X1
Arand, M; Friedberg, T; Härtter, S; Hiemke, C; Oesch, F; Wang, X; Weigmann, H1
Facciolá, G; Hidestrand, M; Tybring, G; von Bahr, C1
Ekstrom, RD; Golden, RN; Lydiard, RB; Mason, GA; Miller, HL1
Altschuler, EL; Kast, RE1
Barton, R1
Weber, K1
Katayama, Y; Katsura, K; Nishiyama, Y; Otori, T; Sunami, E; Usuda, K1
Ioannides, C; Papagiannidou, E; Skene, DJ1
Anderson, GM1
Hooper, PL1

Reviews

2 review(s) available for melatonin and fluvoxamine

ArticleYear
Use of medication in children with psychiatric disorders.
    Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association, 2007, Volume: 80, Issue:11

    Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom

2007
Asperger's syndrome: from hiding to thriving.
    The Nurse practitioner, 2008, Volume: 33, Issue:7

    Topics: Adaptation, Psychological; Asperger Syndrome; Benzodiazepines; Causality; Central Nervous System Depressants; Child; Child Behavior; Diagnosis, Differential; Early Diagnosis; Fluvoxamine; Humans; Interpersonal Relations; Melatonin; Nurse Practitioners; Nursing Assessment; Olanzapine; Prevalence; Primary Health Care; Prognosis; Psychological Tests; Psychology, Child; Risperidone; Serotonin Agents; Social Behavior; United States

2008

Trials

6 trial(s) available for melatonin and fluvoxamine

ArticleYear
Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
    Psychopharmacology, 1990, Volume: 102, Issue:1

    Topics: Adult; beta-Endorphin; Blood Platelets; Double-Blind Method; Fear; Female; Fluvoxamine; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Melatonin; Mental Disorders; Methoxyhydroxyphenylglycol; Norepinephrine; Oximes; Panic; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Ritanserin; Serotonin

1990
Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.
    British journal of clinical pharmacology, 1994, Volume: 37, Issue:2

    Topics: Adult; Analysis of Variance; Desipramine; Fluvoxamine; Humans; Hydrocortisone; Male; Melatonin; Radioimmunoassay

1994
Increased bioavailability of oral melatonin after fluvoxamine coadministration.
    Clinical pharmacology and therapeutics, 2000, Volume: 67, Issue:1

    Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Area Under Curve; Biological Availability; Cytochrome P-450 CYP2D6; Fluvoxamine; Half-Life; Humans; Male; Melatonin; Middle Aged; Reference Values; Selective Serotonin Reuptake Inhibitors

2000
Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
    European journal of clinical pharmacology, 2000, Volume: 56, Issue:2

    Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Citalopram; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Double-Blind Method; Female; Fluvoxamine; Humans; Hydroxylation; Male; Melatonin; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors

2000
Noradrenergic function and clinical outcome in antidepressant pharmacotherapy.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 24, Issue:6

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Depression; Fluvoxamine; Humans; Imipramine; Melatonin; Norepinephrine; Pineal Gland; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2001
A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:10

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cerebral Infarction; Depression; Female; Fluvoxamine; Humans; Male; Melatonin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Stroke

2012

Other Studies

14 other study(ies) available for melatonin and fluvoxamine

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs.
    European journal of pharmacology, 1992, Jun-24, Volume: 217, Issue:1

    Topics: Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluvoxamine; Male; Melatonin; Mianserin; Neurotransmitter Uptake Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine; Sensitivity and Specificity

1992
Melatonin and cortisol increase after fluvoxamine.
    British journal of clinical pharmacology, 1986, Volume: 22, Issue:5

    Topics: Adult; Antidepressive Agents; Circadian Rhythm; Fluvoxamine; Humans; Hydrocortisone; Male; Melatonin; Oximes; Serotonin Antagonists

1986
The influence of acute and subchronic administration of various antidepressants on early morning melatonin plasma levels in healthy subjects: increases following fluvoxamine.
    Journal of neural transmission, 1987, Volume: 68, Issue:3-4

    Topics: Adult; Analysis of Variance; Antidepressive Agents; Blood Platelets; Circadian Rhythm; Female; Fluvoxamine; Humans; Male; Melatonin; Monoamine Oxidase; Osmolar Concentration; Oximes; Serotonin; Time Factors; Tranylcypromine

1987
Fluvoxamine-melatonin-stimulation-test (FMST) in patients with depressive disorders.
    Pharmacopsychiatry, 1988, Volume: 21, Issue:6

    Topics: Adult; Aged; Antidepressive Agents; Depressive Disorder; Dexamethasone; Female; Fluvoxamine; Humans; Male; Melatonin; Middle Aged; Oximes

1988
Melatonin secretion during fluvoxamine treatment in medicated chronic schizophrenic patients: evidence for the development of tolerance to selective serotonin re-uptake inhibitor.
    Biological psychiatry, 1996, Jul-01, Volume: 40, Issue:1

    Topics: Adult; Biomarkers; Chronic Disease; Dose-Response Relationship, Drug; Drug Tolerance; Female; Fluvoxamine; Humans; Male; Melatonin; Psychiatric Status Rating Scales; Schizophrenia; Selective Serotonin Reuptake Inhibitors

1996
Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile.
    Archives of general psychiatry, 2000, Volume: 57, Issue:8

    Topics: Circadian Rhythm; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Hydrocortisone; Melatonin; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome

2000
Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP1A2; Enzyme Inhibitors; Fluvoxamine; Humans; Melatonin; Microsomes, Liver; Serotonin; Theophylline

2001
Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes.
    European journal of clinical pharmacology, 2001, Volume: 56, Issue:12

    Topics: Cells, Cultured; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Melatonin; Microsomes, Liver; Selective Serotonin Reuptake Inhibitors; Substrate Specificity

2001
Co-administration of ramelton and fluvoxamine to increase levels of interleukin-2.
    Medical hypotheses, 2006, Volume: 67, Issue:6

    Topics: Adjuvants, Immunologic; Administration, Oral; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP1A2 Inhibitors; Drug Combinations; Fluvoxamine; Humans; Interleukin-2; Liver; Lymphocytes; Melatonin; Models, Biological; Receptors, Melatonin

2006
Potential drug interactions with melatonin.
    Physiology & behavior, 2014, May-28, Volume: 131

    Topics: 5-Methoxypsoralen; Acetaminophen; Analgesics, Non-Narcotic; Animals; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Central Nervous System Depressants; Diazepam; Drug Interactions; Estrogens; Fluvoxamine; Humans; Hypnotics and Sedatives; Male; Melatonin; Methoxsalen; Microsomes, Liver; Middle Aged; Rats, Wistar; Tamoxifen

2014
Fluvoxamine, melatonin and COVID-19.
    Psychopharmacology, 2021, Volume: 238, Issue:2

    Topics: Clinical Deterioration; COVID-19; Fluvoxamine; Humans; Melatonin; Outpatients; SARS-CoV-2

2021
Heme oxygenase agonists-fluvoxamine, melatonin-are efficacious therapy for Covid-19.
    Cell stress & chaperones, 2022, Volume: 27, Issue:1

    Topics: COVID-19 Drug Treatment; Fluvoxamine; Heme Oxygenase (Decyclizing); Humans; Melatonin; SARS-CoV-2

2022